Your session is about to expire
← Back to Search
Adenotonsillectomy patients for Obstructive Sleep Apnea
N/A
Waitlist Available
Led By adam adler, MD
Research Sponsored by Baylor College of Medicine
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 day
Awards & highlights
Summary
Sleep apnea has become exceedingly recognized in children. The primary treatment for sleep apnea in children is surgery in the form of adenotonsillectomy. The majority of children that undergo adenotonsillectomy are discharged following their immediate recovery in the post anesthesia care unit.
Eligible Conditions
- Obstructive Sleep Apnea
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 day
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 day
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Continuous pulse oximetry following adenotonsillectomy
Trial Design
1Treatment groups
Experimental Treatment
Group I: Adenotonsillectomy patientsExperimental Treatment1 Intervention
Patients having undergone adenotonsillectomy at Texas Children's Hospital admitted for overnight observation based on our institutional protocol will be enrolled. A Wrist OX 3150 (Nonin Medical) will be placed in PACU with saturations recorded until the following morning after the surgery. The patient will undergo pulse oximetry monitoring separately based on the hospital protocol that will be used to guide care. Data from the Wrist Ox will not be avail to the treatment team and will only be analyzed for research purposes.
Find a Location
Who is running the clinical trial?
Baylor College of MedicineLead Sponsor
1,018 Previous Clinical Trials
6,030,929 Total Patients Enrolled
adam adler, MDPrincipal InvestigatorBaylor College of Medicine
1 Previous Clinical Trials
52 Total Patients Enrolled
Share this study with friends
Copy Link
Messenger